Scynexis has resumed dosing of its vaginal yeast infection drug Brexafemme (ibrexafungerp) in a Phase III trial after a ...

Merck KGaA is filing for global regulatory approvals of pimicotinib after it met primary and secondary endpoints in a Phase ...

The US-based START Center for Cancer Research (START) and OneOncology have collaborated to introduce three early-phase trial ...

Gilgamesh managed to overcome the issue of functional unblinding in the study, an obstacle experienced by the psychedelic ...

Rein Therapeutics has dosed the first subject in a Phase II trial of LTI-03, its lead asset for treating idiopathic pulmonary ...

After Lykos' rejection from the FDA last year, companies trying to navigate the psychedelic drug trial sector face various ...

The 12th Outsourcing in Clinical Trials UK & Ireland conference will focus on the region’s future as a clinical trials hub.

The FDA ordered a clinical hold on Rocket Pharmaceuticals' Danon disease trial after the adverse event was first disclosed.

Augustine Therapeutics has initiated subject dosing in the randomised Phase I trial of AGT-100216 for Charcot-Marie-Tooth ...

Huonslab has concluded enrolment of subjects in the Phase I clinical trial, a significant step in the development of the ...

PYC Therapeutics has concluded the first cohort dosing of healthy volunteers in the Phase Ia SAD trial of its drug candidate ...

With the 78th World Health Assembly ending today, all eyes have been on this year’s World Health Organization (WHO) member’s ...